January 2022 Quarterly Performance Report for Phase 2 Study of Cannabis for Veterans with PTSD (MJP2)

On January 14, 2022, MAPS released the first MRA VMR Grant Update for the reporting period ending January 15, 2022 for our Phase 2 Study of Cannabis for Veterans with PTSD (MJP2).

The quarterly performance report includes the following information: 

1. A brief outline of the work accomplished during the reporting period and the work to be completed during the subsequent reporting period

2. A brief description of problems and delays

3. A statement concerning a significant deviation from previously agreed upon Statement of Work

Click here to view the report.